BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 17395134)

  • 1. The nondystrophic myotonias.
    Heatwole CR; Moxley RT
    Neurotherapeutics; 2007 Apr; 4(2):238-51. PubMed ID: 17395134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence study of genetically defined skeletal muscle channelopathies in England.
    Horga A; Raja Rayan DL; Matthews E; Sud R; Fialho D; Durran SC; Burge JA; Portaro S; Davis MB; Haworth A; Hanna MG
    Neurology; 2013 Apr; 80(16):1472-5. PubMed ID: 23516313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum of Nondystrophic Skeletal Muscle Channelopathies in Children.
    Al-Ghamdi F; Darras BT; Ghosh PS
    Pediatr Neurol; 2017 May; 70():26-33. PubMed ID: 28325641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myotonic dystrophy (DM/Curschmann-Steinert disease) and proximal myotonic myopathy (PROMM/Ricker syndrome). Myotonic muscle diseases with multisystemic manifestations].
    Schneider C; Reiners K; Toyka KV
    Nervenarzt; 2001 Aug; 72(8):618-24. PubMed ID: 11519202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle channelopathies.
    Saperstein DS
    Semin Neurol; 2008 Apr; 28(2):260-9. PubMed ID: 18351527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal Muscle Channelopathies.
    Vivekanandam V; Munot P; Hanna MG; Matthews E
    Neurol Clin; 2020 Aug; 38(3):481-491. PubMed ID: 32703462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation spectrum and health status in skeletal muscle channelopathies in Japan.
    Sasaki R; Nakaza M; Furuta M; Fujino H; Kubota T; Takahashi MP
    Neuromuscul Disord; 2020 Jul; 30(7):546-553. PubMed ID: 32660787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Dystrophic and Nondystrophic Myotonias.
    Sansone VA
    Continuum (Minneap Minn); 2016 Dec; 22(6, Muscle and Neuromuscular Junction Disorders):1889-1915. PubMed ID: 27922499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines on clinical presentation and management of nondystrophic myotonias.
    Stunnenberg BC; LoRusso S; Arnold WD; Barohn RJ; Cannon SC; Fontaine B; Griggs RC; Hanna MG; Matthews E; Meola G; Sansone VA; Trivedi JR; van Engelen BGM; Vicart S; Statland JM
    Muscle Nerve; 2020 Oct; 62(4):430-444. PubMed ID: 32270509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A zebrafish model of nondystrophic myotonia with sodium channelopathy.
    Nam TS; Zhang J; Chandrasekaran G; Jeong IY; Li W; Lee SH; Kang KW; Maeng JS; Kang H; Shin HY; Park HC; Kim S; Choi SY; Kim MK
    Neurosci Lett; 2020 Jan; 714():134579. PubMed ID: 31669315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal muscle channelopathies: new insights into the periodic paralyses and nondystrophic myotonias.
    Platt D; Griggs R
    Curr Opin Neurol; 2009 Oct; 22(5):524-31. PubMed ID: 19571750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal-muscle channelopathies: periodic paralysis and nondystrophic myotonias.
    Ryan AM; Matthews E; Hanna MG
    Curr Opin Neurol; 2007 Oct; 20(5):558-63. PubMed ID: 17885445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle Channelopathies.
    Trivedi JR
    Continuum (Minneap Minn); 2022 Dec; 28(6):1778-1799. PubMed ID: 36537980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands.
    Stunnenberg BC; Raaphorst J; Deenen JCW; Links TP; Wilde AA; Verbove DJ; Kamsteeg EJ; van den Wijngaard A; Faber CG; van der Wilt GJ; van Engelen BGM; Drost G; Ginjaar HB
    Neuromuscul Disord; 2018 May; 28(5):402-407. PubMed ID: 29606556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle channelopathies.
    Vivekanandam V; Jayaseelan D; Hanna MG
    Handb Clin Neurol; 2023; 195():521-532. PubMed ID: 37562884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle channelopathies.
    Statland J; Phillips L; Trivedi JR
    Neurol Clin; 2014 Aug; 32(3):801-15, x. PubMed ID: 25037091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle channelopathies and electrophysiological approach.
    Cherian A; Baheti NN; Kuruvilla A
    Ann Indian Acad Neurol; 2008 Jan; 11(1):20-7. PubMed ID: 19966974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostics in skeletal muscle channelopathies.
    Vicino A; Brugnoni R; Maggi L
    Expert Rev Mol Diagn; 2023; 23(12):1175-1193. PubMed ID: 38009256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle channelopathies: the nondystrophic myotonias and periodic paralyses.
    Statland JM; Barohn RJ
    Continuum (Minneap Minn); 2013 Dec; 19(6 Muscle Disease):1598-614. PubMed ID: 24305449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel insights into the pathomechanisms of skeletal muscle channelopathies.
    Burge JA; Hanna MG
    Curr Neurol Neurosci Rep; 2012 Feb; 12(1):62-9. PubMed ID: 22083238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.